A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer
Clinical trial NCT00060944 · COMPLETED
Trial details
- NCT number
- NCT00060944
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2008-05-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.